EUVIMEDEUVIMED entdecken
Crossref

Macrophage-Targeted ROS-Responsive Nanoplatform for Coordinated NF-κB and Nrf2 Modulation in Atherosclerosis Therapy

Jin Liu, Bo Li iD, Yunlong Tian, Huan Zhang, Yanan Shi, Sha Liu

ACS Applied Materials & Interfaces · 2026

DOI: 10.1021/acsami.6c07257 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, 2026. Verfasst von Jin Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation, Ministry of Education, Collaborative Innovation Center of Advanced …. Hauptthemen laut MEDLINE: Reactive Oxygen Species, Atherosclerosis, Macrophages, NF-kappa B. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: Natural Science Foundation of Shandong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Atherosclerosis (AS) is a progressive cardiovascular disease characterized by arterial plaque formation, macrophage-driven inflammation, and excessive accumulation of reactive oxygen species (ROS). However, current clinical interventions remain limited by restenosis and thrombosis, while conventional pharmacotherapies suffer from poor bioavailability and off-target toxicity, highlighting the urgent need for more effective and targeted therapeutic strategies. To address the need for precise intervention, we engineered a multifunctional liposomal platform (Rh-ManLP@Ce) designed to synergize active targeting capabilities with environment-responsive payload release. Central to this design is the synthesis of DSPE-PEG-Rhein, a modification that not only significantly improves the solubility and stability of Rhein but also enables its seamless integration into the lipid bilayer, serving simultaneously as a structural element and a therapeutic agent. By incorporating ROS-responsive lipids into this carrier backbone, the system is programmed to undergo rapid structural disassembly solely within the high-ROS plaque microenvironment, ensuring drug release is strictly triggered by local pathological conditions. Further refining its specificity, the liposome surface is decorated with mannose ligands to actively target macrophage mannose receptors, culminating in the construction of the final Cerium Oxide (CeO2)-loaded nanotherapeutic system (Rh-ManLP@Ce). In vitro experiments and in vivo model results confirm that Rh-ManLP@Ce exhibits superior responsiveness in high-ROS contexts and is efficiently internalized by macrophages, achieving significant accumulation within atherosclerotic lesions. At the molecular level, the system orchestrates a dual synergistic effect via Rhein inhibiting the inflammatory NF-κB pathway, while the CeO2 concurrently activates the antioxidant Nrf2 pathway. This coordinated action effectively remodels the pathological microenvironment and suppresses foam cell formation, ultimately delaying plaque progression. Consequently, this work presents a robust, precise strategy for managing atherosclerosis, offering broad implications for therapeutic interventions in other diseases driven by oxidative stress and inflammation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Reactive Oxygen SpeciesAtherosclerosisMacrophagesNF-kappa BNF-E2-Related Factor 2AnthraquinonesNanoparticlesAnimalsLiposomesMiceHumansPolyethylene GlycolsRAW 264.7 CellsPhosphatidylethanolamines

Stichwörter der Autor:innen

ROS-responsiveRheinatherosclerosiscerium oxideliposomesmacrophage targeting

Substanzen

Reactive Oxygen SpeciesLiposomesNF-kappa BNF-E2-Related Factor 2AnthraquinonesrheinPolyethylene GlycolsPhosphatidylethanolamines1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-methoxy-poly(ethylene glycol 2000)

Autor:innen und Institutionen

  • School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation, Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Ya…

ORCID-Profile: Bo Li

Förderung

  • Natural Science Foundation of Shandong Province

Zitieren

APA

Liu, J., Li, B., Tian, Y., Zhang, H., Shi, Y., & Liu, S. (2026). Macrophage-Targeted ROS-Responsive Nanoplatform for Coordinated NF-κB and Nrf2 Modulation in Atherosclerosis Therapy. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.6c07257

Vancouver

Liu J, Li B, Tian Y, Zhang H, Shi Y, Liu S. Macrophage-Targeted ROS-Responsive Nanoplatform for Coordinated NF-κB and Nrf2 Modulation in Atherosclerosis Therapy. ACS Applied Materials & Interfaces. 2026. doi:10.1021/acsami.6c07257

BibTeX
@article{Liu2026,
  author = {Liu, Jin and Li, Bo and Tian, Yunlong and Zhang, Huan and Shi, Yanan and Liu, Sha},
  title = {Macrophage-Targeted ROS-Responsive Nanoplatform for Coordinated NF-κB and Nrf2 Modulation in Atherosclerosis Therapy},
  journal = {ACS Applied Materials & Interfaces},
  year = {2026},
  doi = {10.1021/acsami.6c07257}
}
Kostenlos starten →